Kiromic BioPharma, Inc. (KRBPQ) Stock Price & Analysis
Kiromic BioPharma, Inc. (KRBPQ) closed at USD 0 on Friday, October 23, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 23, 2026 session ranged USD 0.01–0.01 on volume of 10,000 shares. Market capitalization is $265, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, retrieved October 24, 2026 at 14:23 UTC.
Also available as compact Markdown for AI agents: nexqual.com/KRBPQ.md
Key facts (KRBPQ)
- Analysts: None.
- Total return with dividends: 1Y -98.0% vs S&P 500 +13.4%; 5Y -100.0% vs S&P 500 +76.9%.
Analysts (KRBPQ)
Consensus None.
Total return (dividends reinvested) (KRBPQ)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -98.0% | -100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -98.0% | -93.2% |
| Volatility (annualized) | 446.1% | 283.8% |
| Max drawdown | -99.8% (Oct 2025→Feb 2026) | -100.0% (Nov 2021→Feb 2026) |
KRBPQ analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2022) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2022) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 14:23 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 10,000 shares |
| Market Cap | $265 |
| Exchange | PNK |
Technical Analysis (KRBPQ)
Nexqual's technical model rates KRBPQ "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 14:23 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (KRBPQ)
Wall Street analysts rate KRBPQ "None", per Nexqual as of October 24, 2026 at 14:23 UTC.
| Consensus Rating | None |
|---|
Earnings (KRBPQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-09-30 | USD -15.9 vs est -16.8 ▲ beat |
| 2022-06-30 | USD -16.2 vs est -12.3 ▼ miss |
| 2022-03-31 | USD -14.4 vs est -8.7 ▼ miss |
| 2021-12-31 | USD -21.51 vs est -11.4 ▼ miss |
Source: Nexqual, October 24, 2026 at 14:23 UTC.
Financials & Fundamentals (KRBPQ)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.16 |
| Total Cash | $1.14M |
| Total Debt | $14.57M |
Source: Nexqual, October 24, 2026 at 14:23 UTC.
Financial Health Score (KRBPQ)
Nexqual rates Kiromic BioPharma, Inc.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 14:23 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $1M cash vs $15M debt |
| Cash Flow | Weak — Operating cash flow -$19M (TTM) |
| Efficiency | Mixed — No data |
Ownership (KRBPQ)
| Insider Ownership | +2.29% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.65M |
| Float | 1.19M |
| Short % of Float | +6.82% |
Source: Nexqual, October 24, 2026 at 14:23 UTC.
Leadership (KRBPQ)
Kiromic BioPharma, Inc. is led by Pietro Bersani, Chief Executive Officer, per Nexqual as of October 24, 2026 at 14:23 UTC.
| Chief Executive Officer | Pietro Bersani |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorpor | USD 303.53 | ▼ 1.39% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 89.27 | ▼ 1.79% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.09 | ▼ 0.35% |
| PRAX | Praxis Precision Medicines, Inc | USD 252.96 | ▼ 2.3% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 42.93 | ▼ 2.23% |
| AXSM | Axsome Therapeutics, Inc. | USD 145.04 | ▼ 7.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 14:23 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt